View Author
scopus: 26530691600

Boode, B.S.P.

(Bep Boode)


stroke patient atrial fibrillation atrial fibrillation study aspirin patient age prevention ischemic stroke therapy trial scheme 100 patient-years ischemic stroke prevention warfarin swets subs service factor analysis participant treatment heart failure event outcome heart antithrombotic therapy randomized patient-year nonvalvular atrial fibrillation table point hemorrhage arch intern med nonrheumatic atrial fibrillation risk factors atrial fibrillation investigators investigator ann intern med group failure anticoagulation hazard ratio effect figure non-rheumatic atrial fibrillation framingham result diabetes hypertension model antithrombotic af patients aspirin therapy hazard service ratio score stratification placebo interaction stroke risk university downloaded intern benefit february nonvalvular randomization chads 2 randomized trials stroke rates embolism efficacy prevention participants cohort ischemia อป0.0001 increase stroke rate




2 Most Recent Publications

Effect of age on stroke prevention therapy in patients with atrial fibrillation: the atrial fibrillation investigators (Article)
Walraven, C. van Hart, R.G. Boode, B.S.P. Ezekowitz, M.D. Singer, D.E. Connolly, S.J. Austin, P.C. Mant, J. Hobbs, F.D.R. Koudstaal, P.J. Petersen, P. Perez-Gomez, F. Knottnerus, J.A.
2009-04-01
Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin (Article)
Gage, B.F. Walraven, C. van Pearce, L.A. Hart, R.G. Koudstaal, P.J. Boode, B.S.P. Petersen, P.
2004-10-01